文献速递瘢痕与激光

基于免疫浸润与铜死亡相关基因的瘢痕疙瘩预测模型及潜在治疗药物探索

Exploration of a Predictive Model for Keloid and Potential Therapeutic Drugs Based on Immune Infiltration and Cuproptosis-Related Genes.
PubMed 文献 · J Burn Care Res · 2024-01-01

研究利用GEO数据库GSE7890和GSE145725数据集识别瘢痕疙瘩与非瘢痕疙瘩样本间的差异表达基因,通过免疫浸润分析和差异基因鉴定关键基因,构建逻辑回归列线图预测模型并探索潜在治疗药物。识别出FDX1、PDHB和DBT三个关键基因,预测模型曲线下面积为0.859且校准良好,并筛选出32种潜在药物分子。

要点

  • 识别出FDX1、PDHB和DBT三个关键基因,参与乙酰辅酶A生物合成、线粒体基质、氧化还原酶活性和三羧酸循环。
  • 免疫浸润分析提示B细胞、Th1细胞、树突状细胞、T辅助细胞、抗原呈递细胞共抑制和T细胞共抑制参与瘢痕疙瘩。
  • 基于逻辑回归的列线图预测瘢痕疙瘩发生,曲线下面积为0.859且校准良好。

核心结论

  • 本研究识别了瘢痕疙瘩发病中的一些基因和潜在治疗药物,预测模型有助于早期诊断和管理。
  • 需要进一步研究来验证和探索临床意义。

研究设计与样本

  • 从基因表达综合数据库获取微阵列数据集GSE7890和GSE145725,识别瘢痕疙瘩与非瘢痕疙瘩样本间的差异表达基因。
  • 通过免疫浸润分析和差异表达基因鉴定关键基因,并进行基因本体和京都基因与基因组百科全书分析。
  • 识别与关键基因相关的蛋白质-蛋白质相互作用网络、转录因子和微小RNA。
  • 进行逻辑回归分析以开发瘢痕疙瘩发生的预测模型,并识别瘢痕疙瘩治疗的潜在候选药物。

主要发现

  • 识别出三个关键基因FDX1、PDHB和DBT,涉及乙酰辅酶A生物合成、线粒体基质、氧化还原酶活性和三羧酸循环。
  • 免疫浸润分析提示B细胞、Th1细胞、树突状细胞、T辅助细胞、抗原呈递细胞共抑制和T细胞共抑制参与瘢痕疙瘩。
  • 基于逻辑回归的列线图预测瘢痕疙瘩发生,曲线下面积为0.859且校准良好。
  • 识别出32种潜在药物分子,并根据P值提取前10种化合物,显示靶向关键基因的潜力且可能对瘢痕疙瘩有效。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需要进一步研究来验证和探索临床意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of this study was to investigate the correlation between cuproptosis-related genes and immunoinfiltration in keloid, develop a predictive model for keloid occurrence, and explore potential therapeutic drugs. The microarray datasets (GSE7890 and GSE145725) were obtained from Gene Expression Omnibus database to identify the differentially expressed genes (DEGs) between keloid and nonkeloid samples. Key genes were identified through immunoinfiltration analysis and DEGs and then analyzed for Gene Ontology and Kyoto Encyclopedia of Genes and Genomes, followed by the identification of protein-protein interaction networks, transcription factors, and miRNAs associated with key genes. Additionally, a logistic regression analysis was performed to develop a predictive model for keloid occurrence, and potential candidate drugs for keloid treatment were identified. Three key genes (FDX1, PDHB, and DBT) were identified, showing involvement in acetyl-CoA biosynthesis, mitochondrial matrix, oxidoreductase activity, and the tricarboxylic acid cycle. Immune infiltration analysis suggested the involvement of B cells, Th1 cells, dendritic cells, T helper cells, antigen-presenting cell coinhibition, and T cell coinhibition in keloid. These genes were used to develop a logistic regression-based nomogram for predicting keloid occurrence with an area under the curve of 0.859 and good calibration. We identified 32 potential drug molecules and extracted the top 10 compounds based on their P-values, showing promise in targeting key genes and potentially effective against keloid. Our study identified some genes in keloid pathogenesis and potential therapeutic drugs. The predictive model enhances early diagnosis and management. Further research is needed to validate and explore clinical implications.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Liu J, Hu D, Wang Y, et al. Exploration of a Predictive Model for Keloid and Potential Therapeutic Drugs Based on Immune Infiltration and Cuproptosis-Related Genes. J Burn Care Res. 2024. PMID: 38334429. doi:10.1093/jbcr/irae018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。